Work

Doxorubicin, paclitaxel, and cisplatin (ATP) for refractory germ cell tumors.

Year: 2023

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2023.41.16_suppl.e17028

Authors: Jenny Jing Xiang, Matthew T Campbell, Shi-Ming Tu, John C. Araujo, Yago Nieto, John Kent Lin, Lianchun Xiao, Amishi Yogesh Shah, Jianbo Wang

Institutions: The University of Texas MD Anderson Cancer Center, University of Arkansas for Medical Sciences

Language: English

Topic: Testicular diseases and treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4379337106

Cites:

Cited by:

Related to: 10